Hemorrhagic hemangioma in the liver: A case report

Abstract

Hemangioma is the most common type of benign tumor that arises in the liver. Although rupture and hemorrhage of hepatic hemangioma are rare complications, they can be the cause of mortality. The authors report a case of hemorrhagic hepatic hemangioma: in a 54-year-old woman who was admitted with epigastric pain. She had taken oral contraceptives several weeks prior. The results of a blood examination were normal. An abdominal computed tomography scan revealed a tumor in hepatic segment 4, and a hemorrhage inside the cystic mass was suspected. The mass was removed laparoscopically to confirm the tumor properties and control the hemorrhage. The pathologic findings of the resected mass were consistent with hepatic hemangioma with intratumoral hemorrhage. The patient was discharged 8 d after the surgery, without further complications or complaints, and the patient’s condition was found to have improved during follow-up.

Key Words: Hemangioma, Liver, Hemorrhage, Tumor, Complication

Core tip: Hemangioma is the most common type of benign tumor arising in the liver. Although rupture and hemorrhage of hepatic hemangioma are rare complications, they can be fatal. The authors report a case of hemorrhagic hepatic hemangioma. Compared to other benign hepatic tumor masses, the clinical importance of hemangioma can be easily overlooked. However, if the patient exhibits abdominal symptoms with a history associated with increased blood estrogen levels, a careful examination is necessary to determine whether these symptoms might be accompanied by internal hemorrhage.

INTRODUCTION

Hemangioma is the most common type of benign tumor arising in the liver and is frequently detected incidentally during imaging examinations[1]. The prevalence of biopsy-confirmed hemangioma is about 3%-20%, and is most common in middle-aged women[2].

Because patients with hepatic hemangioma often do not have clear symptoms, and most exhibit normal liver function[3], in many cases, tumor progression is monitored without treatment. Treatment becomes necessary when the tumor size increases to the point of causing symptoms such as abdominal pain, vomiting, abdominal discomfort, loss of appetite, or complications such as tumor rupture or hemorrhage[4-6].

Although rupture and hemorrhage of hepatic hemangioma are rare complications, , they can be fatal[7]. While there have been a considerable number of reports on the natural rupture of hemangioma to date[7-10], reports on internal hemorrhage are rare[11-13]. The authors report a case of hemorrhagic hepatic hemangioma diagnosed incidentally during the examination of a 54-year-old woman hospitalized for epigastric pain.

CASE REPORT

A 54-year-old woman was admitted to Keimyung University Dongsan Hospital. She experienced persistent pain in the epigastrium lasting 2 mo, and initially visited a private clinic, where a tumor mass was detected by an ultrasound examination. She continued to experience a dull pain which eventually intensified. She had no history of viral hepatitis, had taken oral contraceptives several weeks prior, and did not experience recent weight loss. Her father had died of lung cancer, but no other notable conditions were present in the family history. On physical examination, her conjunctiva was not pale, jaundice was not observed in her sclera, and no irregular noise was heard from her heart or lungs on auscultation. Her liver was not palpable below the costal margin, but epigastric tenderness was observed without rebound tenderness. No ascites or lower extremity edema was observed.

A blood test identified the following: white blood cell count: 4400/mm³ (normal range: 5200-12000/mm³), hemoglobin level: 12.4 g/dL (normal range: 12-18 g/dL), platelet count: 289000/mm³(normal range: 130000-400000/mm³), alkaline phosphatase (ALP) level: 56 U/L (normal range: 104-338 U/L), aspartate aminotransferase (AST) level: 27 U/L (normal range: 8-38 U/L), alanine transaminase (ALT) level: 16 U/L (normal range: 4-44 U/L), γ-glutamyltransferase (γ-GT) level: 23 U/L (normal range: 16-73 U/L), bilirubin level: 0.9 mg/dL (normal range: 0.0-0.4 mg/dL), HBsAg negative, anti-HBs Ab positive, and anti-HCV Ab negative. Concentrations of all tumor markers were within the normal range: alpha fetoprotein (AFP): 2.96 ng/mL (normal range: < 8.1 ng/mL), carcinoembryonic antigen(CEA): 2.65 ng/mL(normal range: < 2.5 ng/mL), and carbohydrate antigen 19-9 (CA 19-9): 0.60 U/mL (normal range: < 37 U/mL).

An ultrasound examination performed at a private clinic 3 d before admission, and revealed a cystic mass, approximately 5cm in size in the left lobe of the liver. An abdominal computed tomography (CT) scan identified a 44 mm × 28 mm cystic mass in hepatic segment 4 (Figure 1, arrows), and a high density, non-enhanced lesion was found within the cyst (Figure 1). While the overall size and shape of the liver were normal, a number of small cysts were observed. The spleen, pancreas, gall bladder and kidneys were unremarkable. Since hemorrhage inside the cystic mass was suspected upon abdominal CT scan, Doppler sonography was performed. Heterogeneous echotexture was found inside the round and solid mass upon Doppler sonography (Figure 2), but active bleeding was not found. Although a histological examination was performed to confirm the properties of the tumor, a firm conclusion could not be reached from the obtained data. Therefore, to confirm the tumor properties and control the hemorrhage, the mass was removed laparoscopically. The surgically confirmed mass was rubbery and round-shaped, containing necrotic materials and hemorrhagic components. The results of the histological examination of the resected mass were consistent with hepatic hemangioma with intratumoral hemorrhage (Figure 3).

Figure 1 Abdominal dynamic computed tomography findings. A: Precontrast; B: Arterial phase; C: Delayed phase.

Figure 2 Abdominal ultrasonography findings. A: A Round and solid mass with heterogeneous echotexture in hepatic segment 4; B: Doppler sonography showing low vascularity within the mass.

Figure 3 Gross photographic and pathological findings. A: Macroscopic specimen showing intratumoral hemorrhage within hemangioma; B: Variably sized vascular spaces lined with flat endothelial cells and myxoid stroma [hematoxylin-eosin (HE) staining, magnification × 40]; C: Widely dilated vascular spaces filled with thrombi in the resected specimen (HE staining, magnification × 40); D: HE staining, magnification × 100.

The patient was discharged 8 d after the surgery, without further complications or complaints, and the patient’s condition was found to have improved during follow-up.

DISCUSSION

Because most hemangiomas are relatively small, they are typically observed only after significant time has passed. Various imaging techniques are used to diagnose hemangioma; while ultrasound, CT, or magnetic resonance imaging (MRI) are the techniques most often used, occasionally positron emission tomography (PET) or angiography are used for diagnosis. The sensitivities of ultrasound, CT, or MRI are greater than 90%, while specificity reportedly ranges from 55%-85%[14]. Using ultrasound, hemangioma appears as a uniform hyperechoic mass with a relatively clear boundary, but can appear hypoechoic when the mass is accompanied by hemorrhage, fibrosis, or calcification[15]. In multiphasic CT, nodular or spherical contrast enhancement around the tumor edges is observed in the initial contrast phase, and afferent contrast is enhanced as time progresses. In the late contrast phase, contrast is uniformly enhanced in the entire tumor[16]. In addition, when intratumoral hemorrhage is present, the hemangioma appears as a mass with a highly dense interior[13].

A hemangioma larger than 4 cm is classified as a “giant hemangioma”[17] and causes abdominal discomfort or pain as the tumor size increases. Treatment, including surgery, is necessary for giant hemangioma accompanied by symptoms or complications[4-6]. The most serious complications include tumor rupture, internal hemorrhage, and a coagulation disorder called Kasabach-Merritt syndrome. Since the mortality rate is very high when these complications occur, immediate treatment is necessary. Because the patient in the current case complained of epigastric pain, and a hemangioma larger than 4 cm accompanied by internal hemorrhage was found upon examination, immediate treatment was considered necessary, and surgery was performed.

The treatment methods for hepatic hemangioma include transarterial embolization, radiological therapy, and liver transplantation, in addition to surgical resection[6,18]. Transarterial embolization increases surgical safety by reducing hemorrhage. Radiotherapy and hepatic artery ligation therapy are known to be less effective than transarterial embolization. Liver transplantation is an option for treating giant hemangioma for which surgical resection is impossible[19]. In a recent report, a hemangioma was shrunk using monoclonal antibodies such as bevacizumab[14] or sorafenib[20].

While the pathophysiology of hemangioma is not clearly defined, it is known that abnormal vasculogenesis and angiogenesis may be involved[21]. These processes are prompted by an increase in angiogenic factors such as vascular endothelial growth factors (VEGF) and matrix metalloproteinases (MMPs) and a decrease in anti-angiogenic factors[22,23]. Tumor growth is promoted by high blood estrogen levels during puberty, pregnancy, oral contraceptive use, and androgen treatment[2]. The patient in the current case had taken oral birth control pills for an extended period of time, and there is a possibility that this led to an internal hemorrhage in the hemangioma.

Reports on internal hemorrhage of hemangioma are very rare, and only three cases have been reported worldwide. Graham et al[12] reported a case of internal hemorrhage of hemangioma in a pregnant patient, and Shimoji et al[13] reported a case of hemangioma accompanied by subacute hemorrhage and hemorrhagic anemia in a patient who was undergoing a 5-year follow-up after being diagnosed with hemangioma. Feldman et al[11] reported a case of internal hemorrhage of hemangioma in a 39-year-old man without any indicative factors in his history. Although there have been cases of hemangioma rupture in Korea, there have been no reported cases of internal hemorrhage of hemangioma. Compared to other benign hepatic tumor masses, the clinical importance of hemangioma can be easily overlooked, since it is relatively common and mostly asymptomatic. However, if the patient exhibits abdominal symptoms with a history indicative of increased blood estrogen levels, a careful examination is necessary to determine whether these symptoms might be accompanied by internal hemorrhage.

COMMENTS

Case characteristics

A 54-year-old female with a history of taking oral contraceptives presented with epigastric pain.

Clinical diagnosis

Hepatic hemangioma.

Differential diagnosis

Hepatic adenoma, sarcoma, hepatocellular carcinoma.

Laboratory diagnosis

WBC 4400/mm³; HGB 12.4 g/dL; liver function test and tumor markers were within normal limits.

Imaging diagnosis

Computed tomography scan showed a cystic mass in hepatic segment 4, and intratumoral hemorrhage was suspected.

Pathological diagnosis

Pathologic review revealed a hepatic hemangioma with intratumoral hemorrhage.

Treatment

The patient was treated with laparoscopic removal of the mass.

Related reports

Reports on internal hemorrhage of hemangioma are very rare, and only three cases have been reported worldwide.

Experiences and lessons

A careful examination is necessary to determine whether the patient’s symptoms might be accompanied by internal hemorrhage

Peer-review

The authors described an uncommon and interesting case of a patient with hemorrhagic hepatic hemangioma and they reviewed 3 documented cases with intratumoral hemorrhage in hepatic hemangioma.